Histogen
Utility Patents

Last updated: 8 Sep 2025

Status	Patent	Filling date	Issue date
Grant	Utility: (S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetra- fluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases Filling date: 8 Sep 2025 Issue date: 20 Sep 2022	28 Jun 2019	20 Sep 2022
Grant	Utility: Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions Filling date: 8 Sep 2025 Issue date: 15 Mar 2022	17 Jan 2020	15 Mar 2022

Showing 1 to 2 of 2 patents.